NCT00002165View on ClinicalTrials.gov

Viracept Expanded Access Program

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

Trial Locations (1)

92121

Agouron Pharmaceuticals Inc, San Diego

Sponsors
All Listed Sponsors
lead

Agouron Pharmaceuticals

INDUSTRY

NCT00002165 - Viracept Expanded Access Program | Biotech Hunter | Biotech Hunter